Regret concerning treatment decisions in patients with primary or secondary brain tumors – a cross-sectional exploratory bicentric analysis - Takeaways - MDSpire

Regret concerning treatment decisions in patients with primary or secondary brain tumors – a cross-sectional exploratory bicentric analysis

  • By

  • Julia Reuter

  • Tim Werfel

  • Alexander Rühle

  • Georg Wurschi

  • Anja Mehnert-Theuerkauf

  • Johannes Wach

  • Klaus Pietschmann

  • Tomas Kazda

  • Maximilian Römer

  • Nils H. Nicolay

  • Andreas Hinz

  • Clemens Seidel

  • March 25, 2026

  • 0 min

Share

  • 1

    The study investigates decision regret (DR) in patients with high- and low-grade gliomas and brain metastases undergoing various treatments.

  • 2

    DR is defined as dissatisfaction with past healthcare decisions and can negatively impact emotional and physical well-being.

  • 3

    Factors influencing DR include treatment-related toxicities, disease progression, psychological distress, and decision-making involvement.

  • 4

    The study utilizes the Decision Regret Scale (DRS) to assess regret associated with treatment decisions in brain tumor patients.

  • 5

    Findings may highlight the need for improved shared decision-making processes to enhance patient satisfaction and reduce long-term distress.

Original Source(s)

Related Content